Literature DB >> 8556268

Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.

M Minami1, H Tamakai, T Ogawa, T Endo, N Hamaue, M Hirafuji, M Yoshioka, P R Blower.   

Abstract

In species which vomit, elevated intestinal serotonin (5-hydroxytryptamine, 5-HT) may stimulate abdominal vagal afferent fibers, which in turn evoke the vomiting reflex. The release of 5-HT from intestinal enterochromaffin (EC) cells is regulated by polymodal mechanisms. The object of this study was to evaluate the involvement of 5-HT autoreceptors in the regulation of 5-HT release from the small intestine. Functional studies were carried out using 5-HT3 receptor agonist and antagonists, and 5-HT4 receptor agonist. Ferret and rat ileal tissue were isolated and 5-HT released into the bathing solution was determined using HPLC with an electrochemical detector (ECD). We previously reported that cisplatin produced a significant increase in cumulative 5-HT release and that ondansetron, a selective 5-HT3 receptor antagonist, did not alter the 5-HT release from the ferret ileum. In this study, a selective 5-HT3 agonist, 2-methyl-5-HT, induced a dose-dependent increase of 5-HT from the rat ileum. This release of 5-HT was significantly reduced by granisetron, a selective 5-HT3 receptor antagonist. Furthermore, a selective 5-HT4 receptor agonist, 5-methoxytryptamine induced a concentration-dependent increase of 5-HT in the rat ileum. These results suggest that both 5-HT3 and 5-HT4 receptors may be involved in intestinal 5-HT release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556268

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  3 in total

1.  Real-time measurement of serotonin release and motility in guinea pig ileum.

Authors:  Paul P Bertrand
Journal:  J Physiol       Date:  2006-09-07       Impact factor: 5.182

2.  5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone.

Authors:  A du Bois; W Vach; R Holy; H Kriesinger-Schröder
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

3.  Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).

Authors:  Seetha Chebolu; Yaozhi Wang; Andrew P Ray; Nissar A Darmani
Journal:  Eur J Pharmacol       Date:  2009-11-24       Impact factor: 4.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.